Clinical experience with oxendolone for treatment of benign prostatic hyperplasia. Clinical efficacy and effects on serum lipid and lipoprotein fraction levels

Forty-three patients with benign prostatic hyperplasia were treated with weekly i.m. injections of 400 mg oxendolone for 12 weeks. The subjective symptoms were improved in 83% of these patients. Residual urine was decreased significantly and Qmax was increased by this treatment. Serum VLDL level was...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 30(1984), 4 vom: 01. Apr., Seite 537-43
1. Verfasser:	Yasukawa, A (VerfasserIn)
Weitere Verfasser:	Nihira, H, Matsuki, S, Fujii, M, Fujiwara, H, Kitano, T, Kodama, M, Ukai, R, Tado, O, Sagami, K
Format:	Aufsatz
Sprache:	Japanese
Veröffentlicht:	1984
Zugriff auf das übergeordnete Werk:	Hinyokika kiyo. Acta urologica Japonica
Schlagworte:	English Abstract Journal Article Androgen Antagonists Lipids Lipoproteins Nandrolone 6PG9VR430D oxendolone MN4I850D4P